The outcome of antidepressant use in the medically ill.

No abstract is available for this paper.

• Publication year

  1985

• Venue

  Archives of General Psychiatry

• Publication date

  1985-12-01

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1001/ARCHPSYC.1985.01790350034007PMID 4074108
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A plea for the “naturalistic” study of medicines

  2004cited by this paper
• Consultation-Liaison outcome evaluation system. I. Consultant-consultee interaction.

  1983cited by this paper
• Tricyclic antidepressants and delirium.

  1983cited by this paper
• Diagnosis and neuroanatomical correlates of depression in brain-damaged patients. Implications for a neurology of depression.

  1981cited by this paper
• The significance of secondary depression.

  1981cited by this paper
• Relationship of depression to medical illness. A critical review.

  1981cited by this paper
• Depression in the medically ill.

  1981cited by this paper
• Depression as a major symptom of multiple sclerosis.

  1980cited by this paper
• Neurology for Psychiatrists

  1980cited by this paper
• Secondary depression: familial, clinical, and research perspectives.

  1979cited by this paper
• Depression in Medical In-Patients

  1975cited by this paper
• Confusional episodes and antidepressant medication.

  1971cited by this paper
• Diagnosing depression in medical inpatients.

  1967cited by this paper
• CLINICAL PHARMACOLOGY OF IMIPRAMINE AND RELATED ANTIDEPRESSANT COMPOUNDS.

  1965cited by this paper
• DEPRESSION AMONG MEDICALLY ILL PATIENTS.

  1965cited by this paper
• An inventory for measuring depression.

  1961cited by this paper

• Latin American consensus recommendations for the management and treatment of patients with treatment-resistant depression (TRD).

  2023cites this paper
• A Systematic Review of Long-term Antidepressant Outcomes in Comorbid Depression and Type 2 Diabetes

  2022cites this paper
• Treatment resistant depression

  2021cites this paper
• The IL-6 antagonist tocilizumab is associated with worse depression and related symptoms in the medically ill

  2021cites this paper
• Pharmacological Adjuncts to Palliation in the Trauma Patient: Optimal Symptom Management

  2021cites this paper
• Паллиативная помощь больным с респираторной патологией и критическими состояниями: официальный документ Американского торакального общества Palliative care for patients with respiratory diseases and critical illnesses

  2020cites this paper
• Medicaid spending burden among beneficiaries with treatment-resistant depression.

  2019cites this paper
• Approach to Depression in the Medically Ill

  2018cites this paper
• Antidepressant combination versus antidepressants plus second-generation antipsychotic augmentation in treatment-resistant unipolar depression

  2018cites this paper
• Criminology Theoretical Investigation on Suicidal Acts

  2017cites this paper
• Research & Reviews: Journal of Medical and Health Sciences A Context of Depression and advanced Treatments in Depression

  2015cites this paper
• Depression and Diabetes: Common Link and Challenges of DevelopingEpidemic!!

  2015cites this paper
• Effectiveness of Behavioral Activation Treatment for Depression and HbA1C in Diabetics type II

  2014cites this paper
• Physical co-morbidity among treatment resistant vs. treatment responsive patients with major depressive disorder.

  2013cites this paper
• Sources of Suffering in Patients With Advanced Disease

  2012cites this paper
• Legalization of PAS and Euthanasia Arguments Supporting Legalization of PAS / Euthanasia

  2012cites this paper
• Physical comorbidity and 12-week treatment outcomes in Korean patients with depressive disorders: the CRESCEND study.

  2011cites this paper
• Dosing patterns for duloxetine and predictors of high-dose prescriptions in patients with major depressive disorder: analysis from a United States third-party payer perspective.

  2011cites this paper
• Effect of Methylphenidate and/or Levodopa Combined with Physiotherapy on Mood and Cognition after Stroke: A Randomized, Double-Blind, Placebo-Controlled Trial

  2011cites this paper
• Differentiating and Managing Common Psychiatric Comorbidities Seen in Chronic Pain Patients

  2010cites this paper
• DOCTORAT en MÉDECINE

  2010cites this paper
• Common genetic, clinical, demographic and psychosocial predictors of response to pharmacotherapy in mood and anxiety disorders

  2009cites this paper
• Depressive und Angststörungen bei somatischen Krankheiten

  2009cites this paper
• Use of antipsychotics in the treatment of major depressive disorder in the U.S. Department of Veterans Affairs.

  2009cites this paper
• Sudden gains in depressed cancer patients treated with behavioral activation therapy.

  2009cites this paper
• An official American Thoracic Society clinical policy statement: palliative care for patients with respiratory diseases and critical illnesses.

  2008cites this paper
• Pharmacotherapy for older veterans diagnosed with posttraumatic stress disorder in Veterans Administration.

  2008cites this paper
• Incomplete remission in depression: role of psychiatric and somatic comorbidity

  2008cites this paper
• Is bereavement-related depression different than non-bereavement-related depression?

  2007cites this paper
• Can psychiatric intervention improve major depression in very near end-of-life cancer patients?

  2007cites this paper
• Validity of the bereavement exclusion criterion for the diagnosis of major depressive episode.

  2007cites this paper
• Medical co-morbidity in depressive disorders.

  2007cites this paper
• Treating depression in the medically ill.

  2007cites this paper
• Interpersonal psychotherapy and mirtazapine versus mirtazapine alone in treatment resistant depressed patients with sequential functional brain scans of dopamine D2 receptors with IBZM spect

  2007cites this paper
• Major depressive disorder and medical illness: STAR*D outcomes

  2006cites this paper
• Long term studies of depression: what is relevant for the physician?

  2006cites this paper
• Sertraline for prevention of depression recurrence in diabetes mellitus: a randomized, double-blind, placebo-controlled trial.

  2006cites this paper
• Prescriptive Authority for Psychologists: A Looming Health Hazard?

  2006cites this paper
• A double-blind, multicenter, parallel-group study of paroxetine, desipramine, or placebo in breast cancer patients (stages I, II, III, and IV) with major depression.

  2006cites this paper
• Antidepressant treatment in major depressive disorder comorbid with medical illness

  2005cites this paper
• The prediction of recovery using a multivariate model in 1471 depressed inpatients

  2005cites this paper
• Collaborative care depression management for older adults: level of comorbidity does not affect outcome

  2005cites this paper
• The Impact of Medicalon Acute Treatment in Major Depressive Disorder

  2005cites this paper
• Improving depression outcomes in older adults with comorbid medical illness.

  2005cites this paper
• Referencias

  2005cites this paper
• Symptom management in the older adult.

  2004cites this paper
• Clinical features of depressed outpatients with and without co-occurring general medical conditions in STAR*D.

  2004cites this paper
• Characteristics, treatment patterns, and outcomes of persistent depression despite treatment in primary care.

  2004cites this paper
• Identifying patients at risk for, and treatment of major psychiatric complications of cancer

  2004cites this paper
• Pain Relief Associated with Relief of Depressive Symptoms Table 4 . PaIn Relief Independent of Antidepressant Effect No

  2004cites this paper
• Impact of medical comorbid disease on antidepressant treatment of major depressive disorder

  2004cites this paper
• Effect of medical comorbidity on response to fluoxetine augmentation or dose increase in outpatients with treatment-resistant depression.

  2004cites this paper
• Comorbid medical illness and relapse of major depressive disorder in the continuation phase of treatment.

  2004cites this paper
• Axis III disorders in treatment-resistant major depressive disorder.

  2003cites this paper
• Palliative Care for End-Stage Lung Disease Patients

  2003cites this paper
• Diagnosis and Treatment of Depression in the Elderly Medicare Population: Predictors, Disparities, and Trends

  2003cites this paper
• Comorbidity and depression treatment.

  2003cites this paper
• Konsiliar- und Liaisonpsychiatrie

  2003cites this paper
• New approaches to managing difficult-to-treat depressions.

  2003cites this paper
• Prescriptive Authority for Psychologists: Despite Deficits in Education and Knowledge?

  2003cites this paper
• Depressiv-ängstliche Störungen bei somatischen Krankheiten

  2003cites this paper
• The impact of medical comorbidity on acute treatment in major depressive disorder.

  2003cites this paper
• Affective disorders in advanced cancer.

  2002cites this paper
• Late‐Life Depression in Primary Care: A Nationwide Italian Epidemiological Survey

  2002cites this paper
• A reevaluation of the exclusion criteria used in antidepressant efficacy trials.

  2002cites this paper
• Interaktionen von somatischer Erkrankung und psychiatrischer Behandlung in der stationären Versorgung

  2002cites this paper
• Adverse reactions to antidepressants in consultation-liaison psychiatry inpatients.

  2002cites this paper
• Clinical experience of the pharmacological treatment algorithm for major depression in advanced cancer patients: preliminary study

  2002cites this paper
• Improving the care for depression in patients with comorbid medical illness.

  2002cites this paper
• Consultation-liaison psychiatrists' use of antidepressants in the physically ill.

  2002cites this paper
• Effects of fluvoxamine on morphine-induced inhibition of gastrointestinal transit, antinociception and hyperlocomotion in mice.

  2001cites this paper
• Psychiatric dimensions of palliative care.

  2001cites this paper
• Psychiatric Aspects of the End of Life

  2001cites this paper
• Clinical features of treatment-resistant depression.

  2001cites this paper
• Depression and anxiety in oncology: the psychiatrist's perspective.

  2001cites this paper
• Depression and anxiety disorders.

  2001cites this paper
• Treatment of depression in patients with breast cancer: a comparison between paroxetine and amitriptyline

  2001cites this paper
• Cure palliative nel paziente anziano terminale

  2000cites this paper
• Feasibility and Effectiveness of Treatments for Depression in Elderly Medical Inpatients: A Systematic Review

  2000cites this paper
• Therapieresistente Depressionen — ein therapeutisches Dilemma?

  2000cites this paper
• Geriatric Psychopharmacology: Why Does Age Matter?

  2000cites this paper
• Why are patients prescribed psychotropic drugs by general practitioners? Results of an international study

  2000cites this paper
• Psychotherapy and Psychosomatics , 1999 ; 68 : 3 – 14 Raising Questions about Antidepressants

  2000cites this paper
• Die Betreuung dementer/depressiver Patienten durch niedergelassene Nervenärzte Hamburgs

  2000cites this paper
• The effectiveness of the treatment of depression in the physically ill elderly

  2000cites this paper
• Psychiatrische Aspekte des Lebensendes

  2000cites this paper
• [Depression and somatic diseases. On one retrospective study of 210 patients with major depression hospitalized in a psychiatric hospital].

  1999cites this paper
• Depression in breast cancer patients: the need for treatment.

  1999cites this paper
• Raising Questions about Antidepressants

  1999cites this paper
• A survey of antidepressant prescribing in the terminally ill

  1999cites this paper
• Physician-Assisted Suicide: The Influence of Psychosocial Issues.

  1999cites this paper
• Depression in the medical setting: biopsychological interactions and treatment considerations.

  1999cites this paper
• Psychotherapeutic agents in older adults. Commonly prescribed and over-the-counter remedies: causes of confusion.

  1998cites this paper
• Treatment of major depression in HIV-seropositive men. HIV Neurobehavioral Research Center Group.

  1998cites this paper
• Methylphenidate in terminal depression.

  1998cites this paper
• Psychiatric Aspects of Diabetes Mellitus

  1998cites this paper
• Treatment-resistant depression: clinical significance, concept and management.

  1998cites this paper
• Treatment of depressive symptoms in human immunodeficiency virus-positive patients.

  1998cites this paper
• Depression in Chronic Pain: Mistaken Models, Missed Opportunities

  1998cites this paper
• Buspirone and imipramine for the treatment of major depression in the elderly.

  1998cites this paper